Hepatic damage induced by transcatheter arterial chemoembolization elevates serum concentrations of macrophage-colony stimulating factor

Liver

Volumn 19, Issue 2, 1999, Pages 97-103

  Itoh, Yoshito ^a   Okanoue, Takeshi ^a   Ohnishi, Naoki ^a   Nishioji, Kenichi ^a   Sakamoto, Shinichi ^a   Nagao, Yasuyuki ^a   Nakamura, Hideki ^a   Kirishima, Toshihiko ^a   Kashima, Kei ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

M CSF; Pro inflammatory cytokines; TACE

Indexed keywords

ALANINE AMINOTRANSFERASE; COLLAGEN TYPE 4; COLONY STIMULATING FACTOR 1; CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANGIOGRAPHY; ARTERY EMBOLISM; ARTICLE; ARTIFICIAL EMBOLISM; BLOOD LEVEL; CELL PROLIFERATION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HEPATITIS; HUMAN; HUMAN TISSUE; IN VIVO STUDY; LIVER CELL CARCINOMA; LIVER INJURY; LIVER NECROSIS; MALE; MONONUCLEAR PHAGOCYTE;

EID: 0032997106     PISSN: 01069543     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1478-3231.1999.tb00017.x     Document Type: Article

References (38)

1. KANEMATSU T, FURUTA T, TAKENAKA K, et al. A 5-year experience of lipiodolization: selective regional chemotherapy for 200 patients with hepatocellular carcinoma. Hepatology 1989; 10: 98-102.
2. BRONOWICKI J P, VETTER D, DUMAS F, et al. Transcatheter oily chemoembolization for hepatocellular carcinoma. Cancer 1994; 74: 16-24.
3. SUOU T, YAMADA S, KOBAYASHI J, et al. Changes of serum 7S fragment of type IV collagen and N-terminal propeptide of type III procollagen after transcatheter arterial embolization as a model of acute liver injury. Hepatology 1993; 18: 809-15.
4. YAMASHITA Y, TORASHIMA M, OGUNI T, et al. Liver parenchymal changes after transcatheter arterial embolization therapy for hepatoma: CT evaluation. Abdom Imaging 1993; 18: 352-6.
5. HIGUCHI T, KIKUCHI M, OKAZAKI M. Hepatocellular carcinoma after transcatheter arterial embolization. A histopathological study of 84 resected cases. Cancer 1994; 73: 2259-67.
6. MATSUDA Y, KAWATA S, NAGASE T, et al. Interleukin-6 in transcatheter arterial embolization for patients with hepatocellular carcinoma. Effects of serine protease inhibitor. Cancer 1994; 73: 53-7.
7. IKEI S, OGAWA M, BEPPU T, et al. Changes in IL-6, IL-8, C-reactive protein, and pancreatic secretory trypsin inhibitor after transcatheter arterial chemoembolization therapy for hepatocellular carcinoma. Cytokine 1992; 4: 581-4.
8. TANAKA M, ISHIBASHI H, HAYASHIDA K, et al. Transcatheter arterial embolization or lipiodolization raises the production of tumor necrosis factor activity in patients with hepatocellular carcinoma. Int Hepatol Commun 1994; 2: 74-80.
9. CLARK S C, KAMEN R. The human hematopoietic colony-stimulating factors. Science 1987: 236: 1229-37.
10. BRUGGER W, KREUTZ M, ANDREESEN R. Macrophage colony-stimulating factor is required for human monocyte survival and acts as a cofactor for their terminal differentiation to macrophages in vitro. J Leukoc Biol 1991; 49: 483-8.
11. RAJAVASHISTH T B, ENG R, SHADDUCK R K, et al. Cloning and tissue-specific expression of mouse macrophage colony-stimulating factor mRNA. Proc Natl Acad Sci USA 1987; 84: 1157-61.
12. RAMBALDI A, YOUNG D C, GRIFFIN J D. Expression of the M-CSF (CSF-1) gene by human monocytes. Blood 1987; 69: 1409-13.
13. GRUBER M F, WILLIAMS C C, GERRARD T L, et al. Macrophage-colony-stimulating factor expression by anti-CD45 stimulated human monocytes is transcriptionally upregulated by IL-1β, and inhibited by IL-4 and IL-10. J Immunol 1993; 152: 1354-61.
14. MANTOVANI L, HENSCHLER R, BRACH M A, et al. Regulation of gene expression of macrophage-colony stimulating factor in human fibroblasts by the acute phase response mediators interleukin (IL)-1β, tumor necrosis factor-α and IL-6. FEBS Lett 1991; 280: 97-102.
15. RETTENMIER C W, CHEN J H, ROUSSEL M F, et al. The product of the c-fms proto-oncogene: A glycoprotein with associated tyrosine kinase activity. Science 1985; 228: 320-2.
16. BARTOCCI A, MASTROGIANNIS D S, MIGLIORATI G, et al. Macrophages specifically regulate the concentration of their own growth factor in the circulation. Proc Natl Acad Sei USA 1987; 84: 6179-83.
17. NAITO M, HAYASHI S, YOSHIDA H, et al. Abnormal differentiation of tissue macrophage population in "osteopetrosis" (op) mice defective in the production of macrophage colony-stimulating factor. Am J Pathol 1991; 139: 657-67.
18. HOEDEMAKERS R M J, SCHERPHOF G L, DAEMEN T. Proliferation of rat liver macrophages in vitro: Influence of hemopoietic growth factors. Hepatology 1994; 19: 656-74.
19. MORIYAMA H, YAMAMOTO T, TAKATSUKA H, et al. Expression of macrophage colony-stimulating factor and its receptor in hepatic granulomas of Kupffer-cell-depleted mice. Am J Pathol 1997; 150: 2047-60.
20. ITOH Y, OKANOUE T, SAKAMOTO S, et al. Monokine production by peripheral whole blood in chronic hepatitis C patients treated with Interferon. Dig Dis Sci 1995; 11: 2423-30.
21. ITOH Y, OKANOUE T, SAKAMOTO S, et al. The influence of prednisolone and interferons on serum macrophage-colony stimulating factor concentrations in chronic hepatitis B. J Hepatol 1997; 26: 244-52.
22. ITOH Y, OKANOUE T, ENJYO F, et al. Serum levels of macrophage colony stimulating factor (M-CSF) in liver disease. J Hepatol 1994; 21: 527-35.
23. TANAKA K, ISHIKAWA E, OHMOTO Y, et al. In vitro production of human interleukin 1α and interleukin 1β by peripheral blood mononuclear cells examined by sensitive sandwich enzyme immunoassay. Eur J Immunol 1987; 17: 1527-30.
24. YOSHIOKA K, KAKUMU S, ARAO M, et al. Immunohistochemical studies of intrahepatic tumor necrosis factor α in chronic liver disease. L Clin Pathol 1990; 43: 298-302.
25. KAKUMU S, FUKATSU A, SHINAGAWA T, et al. Localization of intrahepatic interleukin-6 in patients with acute and chronic liver disease. J Clin Pathol 1992; 45: 408-11.
26. ESSNER R, RHOADES K, MCBRIDE, MORTON D L, ECONOMou J S. Different effects of granulocyte-macrophage colony-stimulating factor and macrophage colony-stimulating factor on tumor necrosis factor and interleukin-1 production in human monocytes. J Clin Lab Immunol 1990; 32: 161-6.
27. LEE M-T, KAUSHANSKY K, RALPH P, LADNER M B. Different expression of M-CSF, G-CSF, and GM-CSF by human monocytes. J Leukoc Biol 1990; 47: 275-82.
28. TAOUREL P, DAUZAT M, LAFORTUNE M, et al. Hemodynamic changes after transcatheter arterial embolization of hepatocellular carcinomas. Radiology 1994; 191: 189-92.
29. ITOH Y, OKANOUE T, TSUJI T, et al. Circulating serum hyaluronate and hepatocyte growth factor levels after transcatheter arterial embolization or drug infusion therapy in patients with hepatocellular carcinoma. In: WISSE E, KNOOK DL, WAKE K, eds. Cells of the hepatic sinusoid Vol 5. Kuppfer Cell Foundation, Leiden: Netherland, 1995: 88-89.
30. GIBSON P R, FRÄSER J R E, COLMAN J C, et al. Changes in serum hyaluronan: A simple index of short-term drug-induced changes in hepatic sinusoid. Gastroenterology 1993; 105: 470-4.
31. ERICKSSON S, FRÄSER J R E, LAURENT T C, et al. Endothelial cells are a site of uptake and degradation of hyaluronic acid: A whole body autoradiographic study. Cell Tissue Res 1983; 222: 285-93.
32. RIEDER H, MEYER ZUM BUSCHENFELDE K H, RAMADORI G. Functional spectrum of sinusoidal endothelial liver cells. Filtration, endocytosis, synthetic capacities and intercellular communication. J Hepatol 1992; 15: 237-50.
33. 2-terminal propeptide of type I and III procollagen is a physiological function of the scavenger receptor in liver endothelial cells. J Exp Med 1994; 179: 405-12.
34. MILANI S, HERBST H, SCHUPPAN D, et al. In situ hybridization for procollagen type I, III, and IV mRNA in normal and fibrotic rat liver: evidence for predominant expression in nonparenchymal liver cells. Hepatology 1989; 10: 84-92.
35. NOJI S, TASHIRO K, KOYAMA E, et al. Expression of hepatocyte growth factor gene in endothelial and Kuppfer cells of damaged rat liver, as revealed by in situ hybridization. Biochem Biophys Res Commun 1990; 173: 42-7.
36. SCHIRMACHER P, GEERTS A, PIETRANGELO A, et al. Hepatocyte growth factor/hepatopoietin A is expressed in fat-storing cells from rat liver but not myoblast-like cells derived from fat-storing cells. Hepatology 1992; 15: 5-11.
37. PETERS M, VIERLING J, GERSHWIN M E, et al. Immunology and the liver. Hepatology 1991; 13: 977-94.
38. DE VILLIERS W J S, FRÄSER I P, HUGHES D A, DOLY A G, et al. Macrophage-colony-stimulating selectively enhances macrophage scavenger receptor expression and function. J Exp Med 1994; 180: 705-9.